Advanced Epithelial Ovarian Cancer
Conditions
Interventions
Grouping for survival analysis in patients with advanced ovarian cancer: Primary debulking surgery group (PDS group), Neoadjuvant chemotherapy followed by interval debulking surgery group (NACT-IDS gr
Sponsors
Qilu Hospital of Shandong University
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Complete case data and follow-up data; 2. Postoperative pathology showed that patients with FIGO stage III and IV epithelial ovarian cancer; 3. The patient was treated for the first time and did not receive any relevant treatment before treatment in our hospital; 4. The treatment regimen was initial cytoreductive surgery or neoadjuvant chemotherapy combined with intermediate cytoreductive surgery; 5. The operation was completed by the gynecological oncology team of Qilu Hospital of Shandong University. The patients received standardized treatment after operation and were followed up by outpatient, inpatient or telephone;
Exclusion criteria
Exclusion criteria: 1. After diagnosis, only chemotherapy was given without cytoreductive surgery; 2. Patients with other serious diseases, such as severe liver and kidney function damage, autoimmune diseases, thrombosis and hemorrhagic diseases, delayed treatment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total serum calcium;age;Family history of ovarian cancer;Carbohydrate antigen-153;R level;Carbohydrate antigen-125;Suidan score;Progression free survival;Overall survival;albumin;Neoadjuvant treatment cycles; | — |
Secondary
| Measure | Time frame |
|---|---|
| coronary heart disease;hypertension;weight;Intestinal resection or not;diabetes;History of abdominal and pelvic surgery;Pathological classification;Intraoperative blood loss;Intraoperative blood transfusion;Pathological stage;Operation time; | — |
Countries
China
Contacts
Public ContactHui Zhang
Qilu Hospital of Shandong University
Outcome results
None listed